SCHEMBL9019867

SCHEMBL9019867

CCc1ccc([C@H]2C[C@]3(C)C(=O)CC[C@H]3[C@@H]3CCC4=CC5(CC[C@@H]4[C@H]32)SCCS5)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 2/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA5A P35218 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CYP19A1 P11511 13/20 0.36
▸ PGR P06401 4/20 0.34
▸ AR P10275 3/20 0.34
▸ STS P08842 2/20 0.34
▸ AKR1B10 O60218 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ SHBG P04278 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ SERPINA6 P08185 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ AKR1B1 P15121 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20048420 0.89 PGR (0.45) HSD17B1CYP19A1PGRARSTS
SCHEMBL20048421 0.89 PGR (0.45) HSD17B1CYP19A1PGRARSTS
SCHEMBL10449168 0.88 CYP19A1 (0.36) HSD17B1CYP19A1PGRARSTS
SCHEMBL10448763 0.87 PGR (0.45) HSD17B1CYP19A1PGRARSTS
SCHEMBL8540866 0.86 CYP19A1 (0.35) HSD17B1CYP19A1PGRARSTS
SCHEMBL21470228 0.84 PGR (0.46) HSD17B1CA1CA2CA9CYP19A1
SCHEMBL9019871 0.82 CYP1B1 (0.47) CYP19A1PGRCYP1B1
SCHEMBL8539498 0.82 PDK1 (0.37) CYP19A1PGRARSTSAKR1B10
SCHEMBL21729696 0.74 PGR (0.43) PGRARCYP3A4NR3C1
SCHEMBL9177360 0.73 POLB (0.46) HSD17B1CA1CA2CA5ACA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0404283-B1 11-Beta-aryl-4-estrene, method for its production and its use as a medicine SCHERING AG (DE) 1996-05-08 — — EP disclosed
EP-0404283-A2 11-Beta-aryl-4-estrene, method for its production and its use as a medicine SCHERING AKTIENGESELLSCHAFT (DE) 1990-12-27 — — EP disclosed
Send feedback